 |
PDBsum entry 4yt7
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4yt7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Design and synthesis of potent, Selective phenylimidazole-Based fviia inhibitors.
|
 |
|
Authors
|
 |
P.W.Glunz,
X.Cheng,
D.L.Cheney,
C.A.Weigelt,
A.Wei,
J.M.Luettgen,
P.C.Wong,
R.R.Wexler,
E.S.Priestley.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2015,
25,
2169-2173.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Heterocyclic amide isosteres were incorporated into a phenylglycine-based tissue
factor/factor VIIa (TF-FVIIa) inhibitor chemotype, providing potent inhibitors.
An X-ray co-crystal structure of phenylimidazole 19 suggested that an imidazole
nitrogen atom effectively mimics an amide carbonyl, while the phenyl ring forms
key hydrophobic interactions with the S1' pocket. Exploration of phenylimidazole
substitution led to the discovery of potent, selective and efficacious
inhibitors of TF-FVIIa.
|
 |
|
|
|
|
 |